Clinical Trials for Liver Cancer Patients
Dr. Melanie Thomas is an expert in the field of liver cancer. In this podcast Dr. Thomas describes the process of participating in a clinical trial and the safeguards that are in place to protect a patient's health and privacy. She describes the phases of study for medication approval and what the role of a placebo medication is in a clinical trial, particularly in trials of cancer chemotherapy. (Source: MUSC Cancer Podcast)
Source: MUSC Cancer Podcast - April 5, 2014 Category: Cancer & Oncology Authors: Medical University of South Carolina Source Type: podcasts

Liver Cancer: Research in Primary Liver Cancer
Dr. Melanie Thomas, an expert in the field of gastroenterology, discusses two clinical trials on the horizon at the Hollings Cancer Center of MUSC, each of which focuses on therapy for primary liver cancer. She offers details on the methodology of the clinical studies and notes five other sites around the United States that will augment the work performed at MUSC. Dr. Thomas also identifies eligibility criteria for participation in these studies. To conclude this gastroenterological cancer podcast, Dr. Thomas points to the importance of research in the field of primary liver cancer, which has been previously under-represen...
Source: MUSC Cancer Podcast - April 5, 2014 Category: Cancer & Oncology Authors: Medical University of South Carolina Source Type: podcasts

Cancer: Links to Moderate Drinking Among Middle-Aged Women
Research involving more than a million middle-age women finds that even moderate drinking raises risks for breast, liver, and other cancers. On the other hand, numerous studies have suggested that alcohol, especially red wine, might help deter heart disease - complicating decisions around drinking and health. (Source: MUSC Cancer Podcast)
Source: MUSC Cancer Podcast - April 5, 2014 Category: Cancer & Oncology Authors: Medical University of South Carolina Source Type: podcasts

Cancer: Links to Moderate Drinking Among Middle-Aged Women
Research involving more than a million middle-age women finds that even moderate drinking raises risks for breast, liver, and other cancers. On the other hand, numerous studies have suggested that alcohol, especially red wine, might help deter heart disease - complicating decisions around drinking and health. (Source: MUSC Substance Abuse Podcast)
Source: MUSC Substance Abuse Podcast - April 5, 2014 Category: Addiction Authors: Medical University of South CarolinaMedical University of South Carolina Source Type: podcasts

Liver Tumor Suppressor
(Source: Mayo Clinic - Medical Edge Radio)
Source: Mayo Clinic - Medical Edge Radio - December 24, 2013 Category: Consumer Health Advice Authors: Mayo Clinic Source Type: podcasts

A sugary drinks tax, liver tests in pregnancy
A modelling study on bmj.com suggests that a 20% tax on sugar sweetened drinks would reduce the number of obese adults in the UK by 1.3%, and by 0.9 for those who are overweight. The health gains are fairly similar across all income groups. Oliver Mytton, one of the study's authors, describes why a 20% figure was chosen and how the modelling was... (Source: The BMJ Podcast)
Source: The BMJ Podcast - November 8, 2013 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts

A sugary drinks tax, liver tests in pregnancy
A modelling study on bmj.com suggests that a 20% tax on sugar sweetened drinks would reduce the number of obese adults in the UK by 1.3%, and by 0.9 for those who are overweight. The health gains are fairly similar across all income groups. Oliver Mytton, one of the study's authors, describes why a 20% figure was chosen and how the modelling was done. Also, liver function tests follow a different normal range during pregnancy. Catherine Williamson, professor of women’s health at King's College London, explains why. Read the articles: Overall and income specific effect on prevalence of overweight and obesity of 20% sugar...
Source: The BMJ Podcast - November 8, 2013 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Interpretation and Management of Hepatic Abnormalities in Pregnancy
A review in the November issue of CGH provides a practical guide to evaluation and management of pregnant patients with abnormal liver chemistries or function. Dr. Kuemmerle speaks to Dr. Mary E. Rinella (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - November 6, 2013 Category: Gastroenterology Authors: AGA Source Type: podcasts

The Hidden Epidemic of Liver Disease in Kids
Pediatric fatty liver disease could be an epidemic in the making. (Source: Medscape Gastroenterology Podcast)
Source: Medscape Gastroenterology Podcast - October 8, 2013 Category: Gastroenterology Authors: Medscape Source Type: podcasts

Surgery for liver metastases: How far should and can the surgeon go?
Drs. Mario Dicato and Eric Van Cutsem, along with Dr. Josep Tabernero, chaired the ESMO 15th World Congress on Gastrointestinal Cancer which was held in Barcelona, Spain, 3-6 July 2013. This webcast i... Author: imedex Added: 09/30/2013 (Source: Oncology Tube)
Source: Oncology Tube - September 30, 2013 Category: Cancer & Oncology Source Type: podcasts

Liver directed therapy — When and how?
Drs. Mario Dicato and Eric Van Cutsem, along with Dr. Josep Tabernero, chaired the ESMO 15th World Congress on Gastrointestinal Cancer which was held in Barcelona, Spain, 3-6 July 2013. This webcast i... Author: imedex Added: 09/30/2013 (Source: Oncology Tube)
Source: Oncology Tube - September 30, 2013 Category: Cancer & Oncology Source Type: podcasts

Deny Organ Transplants to Marijuana Users?
It has been said that people who use marijuana shouldn't receive transplants because they may have liver damage or they may not comply with medical regimens. Is it time to revisit that guideline? (Source: Medscape Pulmonary Medicine Podcast)
Source: Medscape Pulmonary Medicine Podcast - September 23, 2013 Category: Respiratory Medicine Authors: Medscape Source Type: podcasts

Deny Organ Transplants to Marijuana Users?
It has been said that people who use marijuana shouldn't receive transplants because they may have liver damage or they may not comply with medical regimens. Is it time to revisit that guideline? (Source: Medscape Family Medicine Podcast)
Source: Medscape Family Medicine Podcast - September 23, 2013 Category: Primary Care Authors: Medscape Source Type: podcasts